Changes

Discussion in 'Centocor Ortho Biotech' started by Anonymous, Apr 24, 2014 at 5:27 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Haney out, Valerini in
     

  2. Anonymous

    Anonymous Guest

    No surprise. V has made it clear he's MYs boy.
     
  3. Anonymous

    Anonymous Guest

    Correction, Mr. H was promoted. I believe it was his 7th promotion in 18 months. Hardly what I would call a failure. It does get cut throat at the top and HQ is loaded with snakes.
     
  4. Anonymous

    Anonymous Guest

    H Promoted? Did you see the title? Puhleeeease. Step Aside little man. Make room for a real marketer like JoeV.
     
  5. Anonymous

    Anonymous Guest

    Bloomberg.com
    JnJ & Pfizer continue talks on possible purchase. Usually the cuts happen after the merger not before.
     
  6. Anonymous

    Anonymous Guest

    Just another brainless ramble by one of you old geezers. JnJ is larger than Pfizer. Just retire already Gramps. You are looking more foolish by the day.
     
  7. Anonymous

    Anonymous Guest

    These posts are what is wrong with JnJ. It makes me ashamed to have ever worked for such a classless operation. There is a reason JnJ is always on the industry bottom. I will enjoy sticking it to you.
     
  8. Anonymous

    Anonymous Guest

    The thing to do is make this what you want it to be. If you want big money get a side gig since the payday here is well over. The point being use this job like this company uses you. They never promised you anything more than a pay check and a role that leaves you unfulfilled. Everything else is up to you.
     
  9. Anonymous

    Anonymous Guest

    The bloom is off the V Rose. Seems there's been some dipping of the personal pen in the company ink, and apparently (who knew?!) that kind of behavior is frowned upon. MY can't save him.
     
  10. Anonymous

    Anonymous Guest

    It does not matter at JnJ. If it did you would have a new CEO and about 1,000 executives would be done. These shameless fools have been "dipping" into the company ink for a very long time. They view it as a right of their position. The dipping is the least of the issues in front of JnJ.

    I believe that the JBI umbrella has gone so far sideways that it is beyond repair. It would be a good time to break this into pieces and spread it to other OpCos. Start by dumping the GI and RA divisions that won't be able to hold their own when Infliximab goes off patent. Seven (yes seven) biologic simulars have filed with the FDA for manufacturing and/or importing of the same starting 2017. Any group selling this product should be sold while a price can be had. In two years you won't be able to give immunology away. Maintain the Derm rights as Ustakinumab is doing well and will remain profitable. Onc is betting on the pipeline for survival but based on history could be a keeper.
    If I sound like a market analyst it is because I am. This is my biz. I recommend your organization focuses on what you do and not what you did. Infliximab paid for the party but new coin is needed for the band to keep playing. So far passing the hat around has not been effective.
    If this poor level of results and under market production continues not even B Hathaway holding will be able to protect your pending fall. I still recommend JnJ as moderate buys and short line but a hit could be coming with if the industry miscalculations continues. At the head or at the tail, the fall will happen either way.
     
  11. Anonymous

    Anonymous Guest

    The heat is on. GI is behind. Maybe he should spend his time on sales, not tail.
     
  12. Anonymous

    Anonymous Guest

    Hopefully JV will get what is coming to him. It is long overdue for his demise.
     
  13. Anonymous

    Anonymous Guest

    V's arrogance is catching up with him. Not making his number and his personal reputation is a mess. But when he's walking around Horsham, he still thinks he's the man. Kind of sad. But not really. Karma
     
  14. Anonymous

    Anonymous Guest

    He's just another Cadillac salesman that weaseled his way into pharma.
     
  15. Anonymous

    Anonymous Guest

    V and his pet monkey PDP are the best! Just ask them and they'll tell you over and over and over. And over.
     
  16. Anonymous

    Anonymous Guest

    For your info: Company under a CIA have legal right to obtain any and all information related to its sales and marketing practices and personnel. That means JBI has had all info on threads for some time. If you feel targeted that might be why. If you notice nobody places info here anymore. You might want to get a cat or dog and whine to that as your career would be better served. No doubt to late for a JNJ one.
     
  17. Anonymous

    Anonymous Guest

    People don't post here cause 99% is BS and all the clever people have left. Only tyrants here now. JBI has nuthin' never did never will. CIA? WTF? Doesn't matter. CP don't store it. Posts are anonymous. Besides who has a static IP address? So you can trace my post all the way to Lima? Great what does that get you if I'm in NYC? If you are feeling targeted, it's because you are tenured and they want you gone by any means. A blind RD could see it. We don't need CP to get rid of you, everything is already in place. Changes are in the works. Sorry legs ya shoulda jumped when ya could.